DAVID ANDREWS (CONSTRUCTION) LIMITED
Company number 02169815 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment
David Andrews (Construction) Limited
1. Financial Health Score: B-
Explanation: The patient is in reasonable condition but displaying symptoms that warrant careful monitoring. While the company benefits from a robust cash position and a 37-year trading history, there are concerning vital signs including declining turnover, eroding net assets, and aggressive dividend extraction. The improving gross margin is a positive vital sign, but the significant drop in net profitability due to one-off charges suggests underlying conditions requiring attention. This is a business that is far from critical condition but is not operating at peak fitness.
2. Key Vital Signs
Revenue Health – Elevated Temperature, Now Cooling
| Year | Turnover | Year-on-Year Change |
|---|---|---|
| 2020 | £8.98M | (COVID impact) |
| 2021 | £11.56M | +28.6% |
| 2022 | £15.66M | +35.4% (peak) |
| 2023 | £15.41M | -1.6% |
| 2024 | £13.03M | -15.4% |
The revenue trajectory shows a business that recovered strongly post-pandemic, peaked in 2022, and is now experiencing a significant contraction. A 15.4% decline in turnover is a symptom that cannot be ignored – this is the financial equivalent of a persistent fever that warrants investigation into whether this is a temporary condition or indicative of a chronic market shift.
Profitability – Conflicting Signals
| Metric | 2023 | 2024 | Change |
|---|---|---|---|
| Gross Margin | 23.8% | 31.4% | +7.6pp ✓ |
| Net Margin | 13.3% | 6.8% | -6.5pp ✗ |
This is the most interesting diagnostic finding. The gross margin has improved significantly – the company is earning more on each pound of revenue before overheads. However, net margin has nearly halved. The directors attribute this to "one-off charges," which acts as a partial explanation but also raises questions about what these charges represent and whether they are truly exceptional.
Balance Sheet Strength – Gradually Weakening
| Year | Net Assets | Change |
|---|---|---|
| 2018 | £6.77M | - |
| 2019 | £6.47M | -4.4% |
| 2020 | £6.53M | +0.9% |
| 2021 | £5.89M | -9.8% |
| 2022 | £5.75M | -2.3% |
| 2023 | £5.73M | -0.4% |
| 2024 | £5.22M | -8.9% |
Net assets have declined by approximately £1.5M over six years. This gradual erosion is the financial equivalent of a slow but consistent loss of bone density – not immediately life-threatening but steadily reducing the company's structural resilience.
Cash Reserves – Healthy Heartbeat
| Year | Cash | Cash as % of Net Assets |
|---|---|---|
| 2020 | £4.96M | 76.0% |
| 2021 | £3.63M | 61.6% |
| 2022 | £3.24M | 56.3% |
| 2023 | £3.14M | 54.8% |
| 2024 | £3.48M | 66.6% |
Cash reserves remain strong at £3.48M. The slight uptick in 2024, combined with the reduction in total liabilities from £4.69M to £2.47M, suggests the company has been deliberately de-leveraging. This is a positive vital sign – the patient has a strong cardiovascular system even if other systems are showing strain.
Leverage – Improving
| Metric | 2023 | 2024 |
|---|---|---|
| Total Liabilities | £4.69M | £2.47M |
| Debt-to-Equity Ratio | 0.82x | 0.47x |
The dramatic reduction in liabilities is encouraging. The debt-to-equity ratio has moved from moderately leveraged to conservatively positioned. This suggests management has prioritized balance sheet repair.
Dividend Policy – Aggressive Extraction
| Year | Dividends |
|---|---|
| 2023 | £519,000 |
| 2024 | £1,014,400 |
Dividends nearly doubled year-on-year. Given that net profit appears to be approximately £500K-£890K (depending on adjustments), a dividend of over £1M means the company is distributing more than it is retaining. This is the financial equivalent of a patient losing more blood than they're producing – sustainable in the short term given existing reserves, but not a sustainable long-term practice.
3. Diagnosis
Primary Condition: Revenue Decline with Aggressive Distribution
The company presents a mixed clinical picture. On examination, there are several positive indicators:
Healthy Signs: - Strong liquidity – £3.48M in cash provides substantial runway - Improving gross margins – 31.4% suggests pricing power and operational efficiency - Significant de-leveraging – liabilities nearly halved year-on-year - Low staff turnover – management notes historically low key staff attrition, critical in a skilled trade - Niche market positioning – high-end London plastering and drylining provides some insulation from commodity competition
Symptoms of Concern: - Declining revenue – 15.4% drop is significant and may reflect market softening - Eroding net assets – consistent year-on-year decline reduces financial resilience - Net margin compression – despite improved gross margins, one-off charges have significantly reduced bottom-line profitability - Aggressive dividend policy – distributing more than annual profit depletes equity reserves - Market concentration risk – heavy exposure to London's high-end residential market, which is sensitive to overseas investor sentiment and global economic conditions - No recurring revenue – the business is entirely contract-dependent with no maintenance income stream
Secondary Condition: Strategic Vulnerability
The strategic report candidly acknowledges the company's susceptibility to global economic shifts, particularly given that many residential projects target overseas investors. This is an honest self-assessment but also highlights a structural vulnerability that the company cannot easily mitigate. The London luxury property market is notoriously cyclical, and a downturn could rapidly contract the available work pipeline.
Prognosis: Guarded but Stable
The immediate prognosis is stable. With £3.48M in cash and significantly reduced liabilities, the company has the financial reserves to weather a downturn. However, the medium-term outlook depends on: 1. Whether the revenue decline is temporary or structural 2. The nature and recurrence of the "one-off charges" 3. Whether dividend policy moderates to retain more earnings 4. The health of the London high-end construction market
4. Recommendations
Immediate Actions (Next 6 Months)
1. Dividend Moderation The dividend of £1.014M exceeds retained profit for the year, resulting in net asset erosion. Recommend moderating future dividends to a maximum of 60-70% of net profit to allow equity rebuilding. This is the financial equivalent of ensuring the patient maintains a healthy blood count rather than bleeding faster than they can replenish.
2. Investigate Revenue Decline Conduct a detailed analysis of the 15.4% revenue drop. Is this due to: - Fewer contracts won? - Lower contract values? - Project delays? - Market softening?
Understanding the root cause will determine whether this is a temporary dip or an early warning of structural change.
3. Clarify One-Off Charges The significant gap between improved gross margins and reduced net margins requires transparency. Stakeholders need to understand whether these charges are truly exceptional or whether they reflect underlying cost pressures that may recur.
Medium-Term Actions (6-18 Months)
4. Diversify Revenue Streams The company's complete dependence on new contract wins, with no recurring maintenance revenue, creates a "feast or famine" cycle. Explore whether there are complementary service offerings (e.g., restoration, maintenance contracts for completed developments) that could provide more predictable income.
5. Geographic or Market Diversification While the high-end London niche has served the company well, concentration in a single market segment creates vulnerability. Consider whether selective expansion into adjacent geographic markets or commercial sub-sectors could reduce risk without diluting the brand's premium positioning.
6. Maintain Cash Discipline The current cash position is a significant strength. Resist the temptation to distribute excess cash through special dividends. A minimum cash reserve of £2.5M should be maintained as a buffer against market downturns – approximately 6-8 months of operating costs based on the current business size.
Long-Term Strategic Considerations
7. Succession Planning The company has a 37-year history with key directors D P Walsh and S Walsh. Low staff turnover is noted as a strength, but key-person dependency at the leadership level represents an unaddressed risk. Formal succession planning should be documented and reviewed annually.
8. Monitor Market Indicators Establish a dashboard of leading indicators for the London high-end property market (planning applications, overseas investor sentiment indices, construction pipeline data) to provide early warning of market shifts.
Summary Financial Health Indicators
| Indicator | Status | Trend |
|---|---|---|
| Liquidity | 🟢 Strong | Improving |
| Leverage | 🟢 Conservative | Improving |
| Profitability (Gross) | 🟢 Healthy | Improving |
| Profitability (Net) | 🟡 Under Pressure | Declining |
| Revenue Growth | 🔴 Contracting | Declining |
| Dividend Sustainability | 🔴 Aggressive | Worsening |
| Market Position | 🟡 Niche but Vulnerable | Stable |
| Balance Sheet Strength | 🟡 Adequate but Eroding | Declining |